PPARG and lung adenocarcinoma: Despite the above, enthusiasm for the use of PPARγ ligands as anticancer agents should be tempered by the fact that PPARγligands stimulated PPARγ transactivation in lung adenocarcinoma cell lines, while few to no effects werenoted in squamous cell or large cell carcinomas.